Imagine a world where every medication, medical device, or healthcare product you use is perfectly controlled, safe, and effective. That’s where the ANSM, the French National Agency for the Safety of Medicines and Health Products, comes in. Created in 2012, this health authority plays a crucial role in ensuring the safety of the French population. It works closely with other institutions such as Santé publique France, the French National Institute of Health and Medical Research (INSERM), and the European Medicines Agency (EMA). The complexity of today’s healthcare system requires rigorous regulation, especially with the constant emergence of new treatments and innovations. Today, the ANSM’s mission goes beyond simply approving products. It extends to continuous monitoring, rigorous evaluation, and rapid response to any potential hazards. All this in a context where citizens’ trust in their healthcare system is paramount, especially as we approach 2025, when the challenges related to pharmacovigilance and health security continue to grow. How exactly does this agency work? What are its specific responsibilities? And why does it play such a central role in our daily lives?
